These findings confirm the dysregulation of IMRGs in ccRCC, consistent with their roles (apart from DBH, CCR4, CMA1 and ENTPD2) in tumor progression and their inclusion in the prognostic model. The gene discussed is DBH; the disease is nonpapillary renal cell carcinoma.